10x Genomics, Inc. TXG Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s other income (expense)?
- 10x Genomics, Inc. (TXG) reported other income (expense) of $4.2M in Q1 2026.
- How has 10x Genomics, Inc.'s other income (expense) changed year-over-year?
- 10x Genomics, Inc.'s other income (expense) decreased by 27.9% year-over-year, from $5.82M to $4.2M.
- What is the long-term trend for 10x Genomics, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s other income (expense) has grown at a 94.9% compound annual growth rate (CAGR), from -$1.46M to $21.08M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.